The effects of secondary prevention after coronary revascularization in Taiwan

BACKGROUND: Secondary prevention therapy for patients with coronary artery disease using an antiplatelet agent, β-blocker, renin-angiotensin system blocker (RASB), or statin plays an important role in the reduction of coronary events after coronary artery bypass grafting (CABG) surgery or percutaneo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Feng, Wen-Han, Chu, Chun-Yuan, Hsu, Po-Chao, Lee, Wen-Hsien, Su, Ho-Ming, Lin, Tsung-Hsien, Yen, Hsueh-Wei, Voon, Wen-Chol, Lai, Wen-Ter, Sheu, Sheng-Hsiung
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6497233/
https://ncbi.nlm.nih.gov/pubmed/31048901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215811
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia